| HOME >> BIOLOGY >> TECHNOLOGY |
NEW YORK, Sept. 1 /PRNewswire/ -- TriMark Publications, LLC (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, cites in its newly published Regenerative Medicine Markets report that the global market for regenerative medicine products will exceed $3 billion in 2010 and is expected to reach $4.5 billion by 2014. Regenerative medicine is a technique to treat injuries and diseases with specially-grown tissues by way of several different methods, including stem cell therapy and tissue engineering.
Before scientific advances such as stem cells, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body's ability to repair itself (or not) or a surgeon's skilled hands. Now, the area of regenerative medicine promises to revolutionize humanity's ability to remedy countless physical maladies that have afflicted humans and other animals through techniques like stem cells and tissue engineering.
In this study, TriMark Publications reviews the market for regenerative medicine solutions. The areas covered in this study include: available and emerging technologies in the field, the U.S. and global market size for regenerative medicine products, and profiles of companies that are focusing on the regenerative medicine sector.
Reasons to Buy TriMark Content
- Data is updated regularly in accordance with changes in the industries our reports cover.
- Information is specifically designed to help individuals who work in the industries the content covers remain competitive in the marketplace.
- Content contains detailed sales data, market share information and emerging trends, all of which impact the sectors companies focused on biotechnology, life sciences, healthcare, pharmaceuticals and medical devices operate in.
- Your competitors are buying TriMark content!
About TriMark Publications, LLC
TriMark Publications is a global leader in the biotechnology, healthcare and life sciences publishing. For more information, please visit http://www.trimarkpublications.com.
Important Notice
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
'/>"/>
| SOURCE TriMark Publications, LLC Copyright©2010 PR Newswire. All rights reserved |
Related biology technology :
1. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
2. NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia
3. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
4. Sigma-Aldrich Enters Into Research Collaboration Program With D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine
5. BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine
6. Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference
7. Novocell Receives a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes
8. Stem Cell Assurance Unveils Physician Network Offering Regenerative Cell Cosmetic and Reconstructive Applications
9. Cell Therapy Group Announces Expansion of Consultants Roster in Regenerative Medicine
10. iPierian Awarded Basic Biology Grant by California Institute of Regenerative Medicine to Study Cellular Reprogramming
11. Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |